Living with a severe degenerative disorder like Duchenne, has always been a waiting game. Yet in recent times, various clinical trials to combat both the underlying mechanism and the cascading effects of Duchenne, raise unprecedented hope to finally ameliorate this common life-limiting genetic disorder. Transparency and scientific rigour have never been more important to families faced with weighing up the risks and benefits of accelerated treatments, on their child’s behalf.
